IDXG - Interpace Diagnostics Group, Inc.
| Previous Close | 0.84 |
| Open | 0.85 |
| Bid | 0.82 x 800 |
| Ask | 0.86 x 800 |
| Day's Range | 0.84 - 0.86 |
| 52 Week Range | 0.72 - 2.05 |
| Volume | 118,421 |
| Avg. Volume | 397,533 |
| Market Cap | 23.41M |
| Beta | 2.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.82 |
| Earnings Date | Aug 14, 2017 - Aug 18, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.50 |
- Thomson Reuters StreetEvents•4 days ago
Edited Transcript of IDXG earnings conference call or presentation 15-May-18 12:30pm GMT
Q1 2018 Interpace Diagnostics Group Inc Earnings Call
- GlobeNewswire•12 days ago
Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
Revenue Grew 39% Over the Prior Year’ s Quarter and 10% Over the Prior Period. Record Quarterly Revenue of $4.8 Million and Record Quarterly Cash Receipts of $4.4 Million. Cash & Cash Equivalents Remain ...
- GlobeNewswire•13 days ago
Interpace Diagnostics Announces Launch of New Thyroid Test
BOSTON, May 14, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests, bioinformatics, and pathology ...
- GlobeNewswire•16 days ago
Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments on Tuesday, May 15, 2018
A webcast replay will be available on the company’s website (www.interpacediagnostics.com) approximately two hours following completion of the call and will be archived on the company’s website for 90 days. Interpace is a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management.
- GlobeNewswire•17 days ago
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
PARSIPPANY, N.J., May 10, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests, bioinformatics, ...
- GlobeNewswire•last month
Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
PARSIPPANY, N.J., April 18, 2018-- Interpace Diagnostics Group, a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services ...
- GlobeNewswire•last month
Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group — What Drives Growth in Today's Competitive Landscape
NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- GlobeNewswire•2 months ago
Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California
PARSIPPANY, N.J., April 02, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services ...
- ACCESSWIRE•2 months ago
Free Research Report as Verisk’s Quarterly Revenue Jumped 12.7%; Adjusted EPS Soared 67.5%
Stock Monitor: Interpace Diagnostics Group Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 02, 2018 / Active-Investors.com has just released a free earnings report on Verisk Analytics, Inc. (NASDAQ: ...
- GlobeNewswire•2 months ago
Interpace Diagnostics Announces Agreement with Acupath Laboratories
PARSIPPANY, N.J., March 28, 2018--. Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology ...
- Zacks•2 months ago
LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
The multi-year, comprehensive laboratory deal to help LabCorp (LH) provide high-quality, high-value and standardized laboratory diagnostics for Appalachian Regional Healthcare.
- GlobeNewswire•2 months ago
Interpace Diagnostics Announces Expansion of LabCorp National Agreement
PARSIPPANY, N.J., March 20, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of IDXG earnings conference call or presentation 15-Mar-18 8:30pm GMT
Q4 2017 Interpace Diagnostics Group Inc Earnings Call
- GlobeNewswire•2 months ago
Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments
Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for the Full Year, Raising $30 Million in Equity and Significantly Improving Balance Sheet and Cash Position, Reimbursement ...
- GlobeNewswire•2 months ago
Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call
PARSIPPANY, N.J., March 14, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services, ...
- GlobeNewswire•3 months ago
New Research Coverage Highlights Great Western, Acadia Realty Trust, Interpace Diagnostics Group, Abercrombie & Fitch, United Rentals, and ZIOPHARM Oncology — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, March 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- GlobeNewswire•3 months ago
Interpace Diagnostics Announces Additional Coverage of Thyroid Tests
PARSIPPANY, N.J., March 08, 2018-- Interpace Diagnostics Group, Inc., a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests and pathology services ...
- Simply Wall St.•5 months ago
What Does Interpace Diagnostics Group Inc’s (NASDAQ:IDXG) Share Price Indicate?
Interpace Diagnostics Group Inc (NASDAQ:IDXG), a healthcare company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM in the over the lastRead More...
Capital Cube•5 months agoInterpace Diagnostics Group, Inc. :IDXG-US: Earnings Analysis: Q3, 2017 By the Numbers : December 18, 2017
Categories: Yahoo FinanceGet free summary analysis Interpace Diagnostics Group, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Interpace Diagnostics Group, Inc. – IQVIA Holdings Inc, TriNet Group, Inc., Pfizer Inc., VIVUS, Inc., Precipio, Inc. and Veeva Systems Inc Class A (IQV-US, TNET-US, PFE-US, VVUS-US, ... Read more (Read more...)
